GlycoRNA clues in glioblastoma: a new path to diagnosis and therapy
Official title: Uncovering glycoRNA landscape in glioblastoma as a novel layer of immune evasion
Funded at University of Texas Hlth Sci Ctr Houston · NIH-11440804 · Data updated 2026-11-12
A small grant is testing a new type of molecular signal called glycoRNAs in glioblastoma to see if it can reveal how the cancer hides from the immune system and help guide new treatments.
Quick facts
| Grant type | R03 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Texas Hlth Sci Ctr Houston NIH-funded |
| Lab location | 1 site (Houston, United States) |
| Project start | September 22, 2026 |
| Project end | August 31, 2028 |
| Funding year | 2026 |
| Award (this year) | $78,000 |
| NIH project number | 1R03NS151007-01 |
| Project ID | NIH-11440804 on NIH RePORTER |
Who could benefit from this research
✓Could help
Patients with glioblastoma or related brain tumor conditions whose samples may be studied or who might be eligible for future diagnostic tests or trials.
✕Less likely to help
Patients without GBM or without access to participating samples may not benefit.
What this research studies
Glioblastoma is a lethal brain cancer with limited treatment success. This project will develop and use a new method to detect glycoRNAs on tumor cells and study how they might influence immune evasion and tumor progression. If glycoRNAs are found to be important, they could become non-invasive biomarkers or new targets for therapy in GBM. The work involves patient-derived tumor material and laboratory analyses to map glycoRNA patterns in GBM cells. Results could lead to earlier diagnosis and more precise treatment options for patients with brain cancer.
Why it matters
Potential benefit: If successful, patients with glioblastoma could benefit from new biomarkers for non-invasive testing and potential therapeutic targets.
How similar studies have gone: GlycoRNA-related roles in cancer and immune interactions have been observed, but their specific role in GBM is not yet established.
Where this research is happening
-
University of Texas Hlth Sci Ctr Houston
Houston, United States Active
Researchers
- Principal investigator: Lee, Tae Jin — University of Texas Hlth Sci Ctr Houston
- Study coordinator: Lee, Tae Jin
Related research
Other NIH-funded projects on the same topics.
-
Small molecules to block Slit2/ROBO in glioblastoma
A study to test small molecule drugs that block Slit2/ROBO signals to help treat glioblastoma in patients.
-
Immunotherapy for glioblastoma: advancing treatment and understanding
A patient-friendly summary of a grant exploring new immune-based treatments for glioblastoma to improve options for people affected by this brain cancer.
-
Small-molecule and biologic treatments for glioblastoma using targeted brain delivery
A new approach aims to use FPS-ZM1 to shrink brain swelling and support immunotherapy for glioblastoma, potentially helping patients recover after surgery.
-
Targeted therapies for glioblastoma in adults and kids
A large NIH program is exploring new brain cancer therapies, including drugs that reach the brain and work against glioblastoma in both children and adults.
-
6-thio-2'-deoxyguanosine for glioblastoma: a new approach to target tumors before surgery
A trial tests a novel drug given before glioblastoma surgery to see how it behaves in the body and within the tumor, and to learn how it affects cancer cells and the immune environment.
-
CD38-Driven Changes in Brain Tumor Metabolism and Immunity in Glioblastoma
A patient-facing look at how scientists plan to study how glioblastoma grows by changing its metabolism and dampening the immune response, with potential targets to help treatment in the future.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.